🔍

Soni Medicare Ltd (539378)

📊 BSE: 539378 🏢 Hospital 📢 Latest filing: 01 Oct 2026

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, Soni Medicare's revenue was ₹4.6 Cr (-39.2% year on year, -30.8% on the previous quarter), and net profit ₹-1.2 Cr (a bigger loss than a year earlier); the operating margin was -19.5%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹4.6	-39.2%	-30.8%
Operating profit	₹-0.9	to loss	to loss
Net profit	₹-1.2	loss widened	loss widened
EPS (₹)	-2.81	loss widened	loss widened
Operating margin	-19.5%	—	—

Full quarterly financials → Results calendar →

📢 Recent Corporate Announcements

Soni Medicare Shareholders Approve FY26 Financials and Loan Limits at 38th AGM

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 01 Oct 2026, 11:08 AM

Soni Medicare Limited has disclosed the voting results of its 38th Annual General Meeting held on September 29, 2026. All six resolutions, including adoption of FY26 financial statements, reappointment of Mrs. Anju Soni, and approval to increase limits for loans and investments under Sections 185 and 186, were approved with 100% of votes cast in favor. Out of 42,64,900 outstanding shares, 29,98,928 shares (70.32%) were polled for general resolutions.

Total voter turnout represented 29,98,928 shares or 70.32% of total outstanding shares on general resolutions
All 6 resolutions passed with 100% votes cast in favor
Special resolutions under Sections 185 and 186 approved to grant loans, give guarantees, and make investments
Appointment of Mr. Lavi Kumar Mutha as Independent Director and Mr. Namit Soni as Executive Director approved

💡 Track subsequent disclosures for any material loans, guarantees, or investments extended under the newly approved Section 185 and 186 headroom, as well as Q2 FY27 earnings.

Soni Medicare Appoints Namit Soni as Additional Executive Director w.e.f. Aug 14, 2026

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 14 Aug 2026, 08:35 PM

Soni Medicare Limited has appointed Mr. Namit Soni as an Additional Executive Director effective August 14, 2026, subject to shareholder approval at the next Annual General Meeting. Mr. Namit Soni is the son of Chairman and Managing Director Mr. Bimal Roy Soni and Non-Executive Director Mrs. Anju Soni. The board induction comes as the microcap healthcare provider operates with a market cap of Rs 31 Cr, TTM revenue of Rs 23 Cr, and a TTM net loss of Rs -4 Cr with negative net worth of Rs -1 Cr.

Appointment of Mr. Namit Soni (DIN: 02910984) as Additional Executive Director effective 14th August 2026
Office tenure valid up to the date of the upcoming Annual General Meeting of the company
Appointee is the son of CMD Mr. Bimal Roy Soni and Non-Executive Director Mrs. Anju Soni
Educational background includes St. Stephens College (2008) and MBA in Marketing from IMI, New Delhi

💡 Track regularisation of the appointment at the upcoming AGM and monitor if new leadership impacts operational recovery from ongoing quarterly losses.

Q1 Net Loss Widens to Rs 1.20 Cr as Revenue Drops 37.4% YoY to Rs 4.55 Cr

🔴 NEGATIVE ⭐ 5/10

EARNINGS 📅 14 Aug 2026, 08:24 PM

Soni Medicare reported a 37.4% YoY decline in revenue from operations to Rs 455.27 lakhs (Rs 4.55 crore) for the quarter ended June 30, 2026, down from Rs 727.71 lakhs in the corresponding prior-year period. Net loss widened sharply to Rs 119.85 lakhs (Rs 1.20 crore) compared to a loss of Rs 29.10 lakhs in Q1 FY26. Total expenses stood at Rs 596.54 lakhs, outpacing total revenue of Rs 477.84 lakhs, with finance costs rising to Rs 39.46 lakhs. Additionally, the company reorganized its segment reporting to operate under a single segment, Healthcare Facilities.

Revenue from operations fell 37.4% YoY to Rs 455.27 lakhs vs Rs 727.71 lakhs in Q1 FY26
Net loss expanded more than fourfold YoY to Rs 119.85 lakhs from Rs 29.10 lakhs
Total income decreased 36.2% YoY to Rs 477.84 lakhs from Rs 749.20 lakhs
Finance costs increased to Rs 39.46 lakhs from Rs 25.33 lakhs in Q1 FY26
Basic and diluted EPS deteriorated to Rs -2.81 vs Rs -0.68 in Q1 FY26

💡 Monitor upcoming quarterly results to see if the company can arrest revenue contraction and reduce operational cash burn, especially given existing debt levels and negative net worth.

Soni Medicare Q1 Net Loss Widens to ₹1.20 Cr; Revenue Drops 37% YoY to ₹4.55 Cr

🔴 NEGATIVE ⭐ 6/10

EARNINGS 📅 14 Aug 2026, 08:17 PM

Soni Medicare reported a weak set of numbers for Q1 (quarter ended June 30, 2026), with operational revenue dropping 37.4% YoY to ₹4.55 crore compared to ₹7.28 crore in the year-ago period. Net loss widened significantly to ₹1.20 crore from ₹0.29 crore in Q1 FY26, driven by top-line de-growth and sticky operating costs. Basic EPS worsened to ₹-2.81 from ₹-0.68 YoY. The company also appointed Mr. Namit Soni as an Additional Executive Director.

Revenue from operations decreased 37.4% YoY to ₹455.27 lakhs (vs ₹727.71 lakhs in Q1 FY26)
Net loss widened to ₹119.85 lakhs against a loss of ₹29.10 lakhs in the same period last year
Total expenses stood at ₹596.54 lakhs, outstripping total income of ₹477.84 lakhs
Diluted EPS came in at ₹-2.81 versus ₹-0.68 in Q1 FY26
Mr. Namit Soni appointed as Additional Executive Director effective August 14, 2026

💡 Track subsequent quarterly operational occupancy and cost containment efforts to see if revenue contraction and cash burn can be arrested given the company's negative net worth.

Soni Medicare Board Meeting on August 14, 2026, to approve Q1 FY27 results

🟡 NEUTRAL ⭐ 3/10

BOARD_MEETING 📅 11 Aug 2026, 11:56 AM

Soni Medicare Ltd has scheduled a board meeting for August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The company is currently in a precarious financial position with a negative net worth of Rs -1 Cr and a TTM net loss of Rs -3 Cr. Revenue has been stagnant, with the March 2026 quarter reporting Rs 6.58 Cr compared to Rs 7.49 Cr in June 2025. The upcoming results will be critical to assess if the company can improve its operating margins, which stood at -3.4% for the TTM period.

Board meeting scheduled for August 14, 2026, to approve Q1 FY27 results.
Trading window for designated persons has been closed since July 1, 2026.
Company reported a TTM revenue of Rs 26 Cr against a market cap of Rs 31 Cr.
Financial health is strained with a negative net worth of Rs -1 Cr and debt of Rs 13 Cr.

💡 Monitor the financial results on August 14 for any signs of operational turnaround or improvement in the negative net worth situation.

Soni Medicare Approves Bank Guarantee from PNB and RGHS Empanelment Process

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 23 Jul 2026, 02:15 PM

Soni Medicare's board has approved obtaining a Bank Guarantee from Punjab National Bank, though the specific amount was not disclosed. The board also authorized the Managing Director to handle all matters related to the Rajasthan Government Health Scheme (RGHS), including registration and renewals. This is a critical operational step for the hospital, as government schemes are major revenue drivers. However, the company remains in a precarious financial position with a negative net worth of ₹-1 Cr and TTM losses of ₹3 Cr.

Board approved obtaining a Bank Guarantee from Punjab National Bank on July 23, 2026.
Managing Director Dr. Bimal Roy Soni authorized for RGHS empanelment and compliance.
Company currently operates with a negative net worth of ₹-1 Cr.
TTM Revenue stands at ₹26 Cr against a market capitalization of ₹21 Cr.
Operating profit margin (OPM) remains negative at -3.4%.

💡 Investors should monitor if the RGHS empanelment leads to improved occupancy rates in upcoming quarterly results, as the company needs to reverse its current loss-making trend to address its negative net worth.

View All 539378 Announcements on Live Market Tracking →